Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
– IMM-BCP-01 already shown to neutralize all other CDC variants of concern in pre-clinical testing
– IND submission planned for this quarter
Comments are closed.